These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Mechanisms of dyspnea in chronic lung disease. Rock LK; Schwartzstein RM Curr Opin Support Palliat Care; 2007 Aug; 1(2):102-8. PubMed ID: 18685350 [TBL] [Abstract][Full Text] [Related]
67. Outcomes of lung transplant candidates referred for co-management by palliative care: A retrospective case series. Colman R; Singer LG; Barua R; Downar J Palliat Med; 2015 May; 29(5):429-35. PubMed ID: 25634636 [TBL] [Abstract][Full Text] [Related]
68. 'INSPIRED' approaches to better care for patients with advanced COPD. Rocker GM; Cook D Clin Invest Med; 2013 Jun; 36(3):E114-20. PubMed ID: 23739664 [TBL] [Abstract][Full Text] [Related]
69. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373 [TBL] [Abstract][Full Text] [Related]
70. Opioids for the Management of Dyspnea in Cancer Patients: Evidence of the Last 15 Years--A Systematic Review. Vargas-Bermúdez A; Cardenal F; Porta-Sales J J Pain Palliat Care Pharmacother; 2015; 29(4):341-52. PubMed ID: 26523974 [TBL] [Abstract][Full Text] [Related]
71. Inhaled nebulized and intranasal opioids for the relief of breathlessness. Bausewein C; Simon ST Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175 [TBL] [Abstract][Full Text] [Related]
72. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. O'Donnell DE; Hamilton AL; Webb KA J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610 [TBL] [Abstract][Full Text] [Related]
73. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. Clemens KE; Klaschik E J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708 [TBL] [Abstract][Full Text] [Related]
74. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review. Maeda T; Hayakawa T J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633 [TBL] [Abstract][Full Text] [Related]
75. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Cooper CB Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896 [TBL] [Abstract][Full Text] [Related]
76. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Allard P; Lamontagne C; Bernard P; Tremblay C J Pain Symptom Manage; 1999 Apr; 17(4):256-65. PubMed ID: 10203878 [TBL] [Abstract][Full Text] [Related]
77. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians. Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876 [TBL] [Abstract][Full Text] [Related]
78. Pain management. O'Laughlin K Am J Nurs; 2002 Mar; 102(3):13-4. PubMed ID: 11976519 [No Abstract] [Full Text] [Related]
79. End-of-life care in patients with chronic obstructive pulmonary disease. Steel A; Goldring J Br J Hosp Med (Lond); 2015 Jan; 76(1):C10-3. PubMed ID: 25585191 [No Abstract] [Full Text] [Related]
80. Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD). Ekström M; Bornefalk-Hermansson A; Abernethy A; Currow D Evid Based Med; 2015 Feb; 20(1):39. PubMed ID: 25564658 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]